younger and lower-risk patients naturally results in longer life expectancy and survival rates
after the intervention. Longer life expectancy of these patients leads to an increased
possibility of future acute coronary events, necessitating the development of effective and
appropriate treatment strategies. Acute coronary syndromes (ACS) in patients with previous
TAVR procedures present with modified clinical characteristics when compared to the non …